eMedicine Specialties > Emergency Medicine > Pediatric

Pediatrics, Appendicitis

Kara E Hennelly, MD, Fellow, Department of Pediatric Emergency Medicine, Children's Hospital Boston
Richard G Bachur, MD, Assistant Professor of Pediatrics, Harvard Medical School; Associate Chief and Fellowship Director, Attending Physician, Division of Emergency Medicine, Children's Hospital of Boston

Updated: Feb 12, 2009

Introduction

Background

Appendicitis, the most common pediatric surgical emergency, is caused by inflammation of the vermiform appendix. Four of 1,000 children younger than age 14 years will be diagnosed with appendicitis. Common symptoms of appendicitis include abdominal pain, fever, and vomiting. The diagnosis of appendicitis can be difficult in children because the classic symptoms are often not present.

A delay in the diagnosis of appendicitis is associated with rupture and associated complications, especially in young children. Improvements in rupture rates have been made with advanced radiologic imaging. Appendicitis is a clinical diagnosis with imaging used to confirm equivocal cases.

Pathophysiology

The appendix arises from the inferior tip of the cecum as a long, thin diverticulum.  For most children, the cecum is located in the right lower quadrant. The base of the appendix is fixed to the cecum. However, the tip can be located in the pelvis, retrocecum, or extraperitoneum.  

The exact function of the appendix is unknown. It is a highly lymphatic structure, suggesting an immunologic role. 

Appendicitis results from a luminal obstruction. This obstruction can be caused by fecaliths, lymphoid hyperplasia, foreign bodies, or parasites. Children and adults have also developed appendicitis following severe blunt abdominal trauma.

Once the appendiceal lumen is blocked, the appendiceal mucosa becomes edematous. A cycle begins where intraluminal pressure increases, inflammation ensues, and exudate drains from the appendix. Fecal bacterial overgrowth occurs within the obstructed lumen, thereby enhancing the inflammatory response and further increasing the intraluminal pressure. The increase in intraluminal pressure leads to a dull generalized discomfort. The patient experiences increased focal pain as the transmural inflammation extends to the peritoneum. 

With delayed diagnosis of appendicitis, the obstruction progresses, the wall of the appendix stretches due to the further rise in intraluminal pressure, and perforation occurs. When the inflammatory fluid and bacterial contents are released into the abdominal cavity, peritonitis develops. Concomitantly, the patient complains of more intense and generalized abdominal pain.

In adults and adolescents, the omentum can wall off the inflamed or perforated appendix, causing a focal abscess. In the younger child, the omentum is less well developed and less likely to wall off a perforation, making peritonitis more likely.

Frequency

United States

• Appendicitis has an incidence of 70,000 pediatric cases per year in the United States.
• Appendicitis has an incidence of 1-2 cases per 10,000 children per year between birth and age 4 years.
• The incidence increases to 25 cases per 10,000 children per year between 10 and 17 years of age. 

Mortality/Morbidity

• The rate of appendiceal perforation is 80-100% for children younger than 3 years compared to less than 10-20% of children aged 10-17 years. 
• The mortality rate for children with appendicitis ranges from 0.1-1%.
• Delay in diagnosis increases perforation rate.

Race

The role of race, ethnicity, health insurance, education, access to health care, and economic status on the development and treatment of appendicitis are widely debated. Cogent arguments have been made on both sides for and against the significance of each socioeconomic or racial condition.

Sex

• The male-to-female ratio of appendicitis is approximately 1.4:1.

Age

Appendicitis occurs in all age groups. The diagnosis of appendicitis in a younger child is more difficult and often the condition is more advanced. 

• Appendicitis affects patients in the second decade of life most frequently (aged 10-19 y), at a rate of 23.3 cases per 10,000 per year.
• The rate of appendicitis in children younger than age 4 years is 1-2 per 10,000 per year. Children younger than 4 years almost universally present after perforation. 
• Appendicitis is extremely rare in the neonate, and the diagnosis in this age group is typically made after perforation.

Clinical

History

Understanding the typical clinical manifestations of appendicitis is essential in order to make an early and accurate diagnosis prior to perforation. The classic history of anorexia and periumbilical pain, followed by right lower quadrant (RLQ) pain, fever, and vomiting, is observed in fewer than 60% of patients.¹ The clinician is more likely to make the diagnosis by maintaining a high degree of suspicion and a broad differential diagnosis, and looking for the atypical case rather than the classic appendicitis.   

Vomiting, RLQ pain, focal tenderness, and guarding are significantly associated with appendicitis.

• The initial symptom is poorly defined periumbilical pain, often associated with anorexia.
  • A unique feature of appendicitis is gradual onset of pain followed by vomiting. Vomiting first is more typical of gastroenteritis. 
  • Abrupt onset of pain should prompt the clinician to consider acute ischemic conditions, such as volvulus, testicular torsion, ovarian torsion, or intussusception.
• After a few hours, the pain migrates to the RLQ due to inflammation of the parietal peritoneum.
  • This pain is more intense, continuous, and more localized than the initial pain.
  • This shift of pain rarely occurs in other abdominal conditions.
• Most children with appendicitis either are afebrile or have a low-grade fever. High fever is not a common presenting feature unless perforation has occurred.
• Becker et al found that 44% of patients diagnosed with appendicitis presented with 6 or more atypical features.²
  • Examples of atypical features include absence of anorexia, nausea, migration of pain, RLQ pain, and pyrexia. 
  • Abrupt onset of pain, diarrhea, and pain longer than 48 hours are further examples of atypical features of appendicitis. 

Physical

Children vary in their ability to cooperate with the physical examination. It is important to tailor the physical examination with respect to the child's age and developmental stage. It is also important to exclude extra-abdominal causes of abdominal pain, such as urinary tract infection (UTI) or pneumonia. 

• In early appendicitis, children may have focal tenderness in the RLQ without significant guarding or peritoneal signs. 
• Observation of the child's interaction and gait prior to the examination can be extremely helpful. If able to stand, asking a child to hop is helpful in assessing for peritoneal irritation. If the child is unwilling to stand, shaking the bed or pelvis can also evaluate for peritoneal signs. 
• A child with advanced appendicitis typically prefers to lie still due to peritoneal irritation.
• The child may have localized guarding or rebound tenderness.
• Typically, maximal tenderness can be found at McBurney's point, which is halfway between the umbilicus and the anterior superior iliac spine in the RLQ.
• On examination, bowel sounds may be decreased.
• Rovsing sign is pain in the RLQ in response to palpation of the left lower quadrant (LLQ), suggestive of peritoneal irritation.
• The psoas sign is elicited by placing the child on the left side and hyperextending the right hip.
• The obturator sign is determined by internal rotation of the flexed right thigh. Pain on movement may be caused by an inflammatory mass overlying the psoas muscle.
• A mass may be palpable in the RLQ if the appendix is perforated.
• An external genitourinary (GU) examination is helpful to rule out testicular or scrotal tenderness in males and hematocolpos in pubertal females. 
• A rectal examination should be performed last and may reveal impacted stool, right-sided tenderness, or a mass. Be sure to perform a rectal examination (inspection, palpation, and digital examination) in children who have any abdominal tenderness, a history of constipation, a history of rectal bleeding, trauma, or suspected physical abuse. A retrocecal appendix may cause exquisite tenderness on rectal examination.
• A pelvic examination should be considered in sexually active females to evaluate for tenderness (adnexal and/or cervical motion tenderness), masses, bleeding, or discharge.

Causes

Appendicitis results from a luminal obstruction. This obstruction can be caused by fecaliths, lymphoid hyperplasia, foreign bodies, or parasites. Children and adults have also developed appendicitis following severe blunt abdominal trauma.

Differential Diagnoses

Other Problems to Be Considered

Lymphoma
Epiploic appendagitis
Paratubal cysts
Inflammatory bowel disease
Volvulus
Typhilitis

Workup

Laboratory Studies

Laboratory findings may increase the suspicion for appendicitis but are not diagnostic.

• A minimum laboratory evaluation for patients with possible appendicitis includes a CBC with differential and urinalysis. Electrolytes may be useful if concern of dehydration or diabetic ketoacidosis. Liver function tests and amylase and lipase levels may additionally be helpful if other diagnoses are considered. 
• The WBC count is neither sensitive nor specific for appendicitis.
  • The WBC count is elevated in approximately 70-90% of patients with acute appendicitis, but it also is elevated in many other abdominal conditions.
  • The predictive value of the WBC count is limited. Because at least 10% of patients with appendicitis have a WBC count within the reference range, appendicitis cannot be excluded based on a normal WBC count. It is important to interpret the WBC count with respect to the clinical presentation.
  • A WBC count of more than 15,000 cells/mm³ is suggestive of perforation. Cardall et al found no difference in the WBC count between children with simple appendicitis and those with a perforated appendicitis.³
• Urinalysis is useful for detecting urinary tract disease, such as infection or renal stones. Pyuria can be present in children with appendicitis.
  • Irritation of the bladder or ureter by an inflamed appendix may result in a few WBCs in the urine, but the presence of more than 20 WBCs/hpf suggests a urinary tract infection or vaginitis.
  • Possible causes of hematuria include renal stones; urinary tract infection; Henoch-Schönlein purpura (HSP); or hemolytic uremic syndrome (HUS), in this case related to hemolysis and not red blood cells by microscopy).
  • Normal findings on urinalysis are of limited diagnostic value for appendicitis. Grossly abnormal urinalysis findings may suggest another cause of abdominal pain.
• C-reactive protein (CRP) is a nonspecific inflammatory marker. A normal CRP does not exclude appendicitis, especially early in the illness.
• Triple test  
  • The triple test consists of CRP, total white blood cell count (WBC), and neutrophil percentage.
  • Positive triple test result is indicated by CRP values of more than 8 mcg/mL, and total WBC count of more than 11,000/µL, and neutrophil percentage of more than 75%.
• Liver function tests, serum amylase level, and serum lipase level may be helpful when the etiology of the abdominal pain is unclear. Electrolytes and renal function tests are more helpful in the management than in the diagnosis of appendicitis. Indications for assessing electrolytes include a significant history of vomiting or clinical suspicion of dehydration.
• Urine human chorionic gonadotropin-beta subunit (hCG) should be obtained to rule out pregnancy (intrauterine and ectopic) in adolescent females.
• Blood cultures should be obtained in an ill-appearing child. 

Imaging Studies

• Abdominal radiography
  • Plain radiographs rarely add to the diagnosis because they are typically normal in appendicitis. 
  • Abdominal radiographs should be obtained in any patient with an examination concerning for intestinal obstruction or with peritoneal signs. 
  • The presence of a calcified appendiceal fecalith occurs in fewer than 10% of cases.
• Ultrasonography is the preferred imaging modality in the evaluation of acute appendicitis in pediatrics when available.
  • Ultrasonography advantages include noninvasiveness, no contrast or radiation exposure, and minimal pain.
  • One disadvantage is that the examination is operator-dependent, and patients with larger body mass indexes (BMIs) are difficult to examine.
  • Ultrasonography has had an overall sensitivity of 85% and specificity of 94% in pediatric patients in experienced hands.⁴  
  • Specific findings can support the diagnosis.
    • The finding of a noncompressible dilated appendix is a strong indicator of nonperforated appendicitis.
    • After perforation, ultrasonography can identify a periappendiceal phlegmon or abscess formation.
    • Additional findings that can support the diagnosis of appendicitis include the presence of appendicoliths, fluid in the appendiceal lumen, focal tenderness over the inflamed appendix, and a transverse diameter of 6 mm or more.
  • Ultrasonography is especially helpful in adolescent females, as it is useful in diagnosing alternate pathology, such as a tubo-ovarian abscess, ovarian torsion, and ovarian cyst.
  • An ultrasonographic image that does not identify the appendix should not be interpreted as normal, but it should prompt further investigation if clinical suspicion remains. 
• CT scan
  • In adults, a CT scan is used widely to diagnose appendicitis.
  • In children, numerous studies have investigated the use of CT in the evaluation of pediatric appendicitis. CT scanning appears to have its greatest value among patients with large BMIs for which ultrasonography is difficult or when ultrasonography is inconclusive. No exact CT protocol is best; some centers use intravenous contrast alone and others use intravenous contrast plus enteral contrast.
  • CT scans are useful for patients in whom the ultrasonographic findings are equivocal.
  • A CT scan may be beneficial in complicated cases with abscess formation and bowel-wall thickening. For such cases, oral contrast is most helpful for defining the abscess.

Treatment

Prehospital Care

Emergency medical service (EMS) personnel are well-trained and cognizant of how to assess and begin treatment of the febrile, vomiting, child with abdominal pain.

Intravenous fluid administration, pain management, and antiemetic medication should be administered based on local EMS protocols.

Emergency Department Care

One of the difficult challenges in evaluating children with abdominal pain is making a timely diagnosis prior to appendiceal perforation. In the ED, classifying patients with abdominal pain into the following 3 categories may be helpful:

• Diagnosis not consistent with appendicitis
  • This group includes patients whose history and physical examination are not consistent with appendicitis, classic or atypical. These patients have a nonconcerning abdominal examination and history.
  • Importantly, a complete physical examination should be completed before discharge from the ED.
• Classic history for appendicitis
  • Patients with a classic history for appendicitis should undergo surgical consultation. Further imaging and laboratory data may be requested to confirm the diagnosis. Any patient with peritoneal signs should also have a surgical evaluation. 
  • Antibiotic therapy is an important aspect of the treatment of ruptured appendicitis. Antibiotic therapy should be directed against gram-negative and anaerobic organisms such as Escherichia coli and Bacteroides species. The administration of antibiotics, nasogastric tubes (when necessary), intravenous lines, urethral catheters (when necessary), antiemetic medicine, antipyretic medicine, and analgesia should ideally be part of the ED protocol for managing the preoperative child. Patients should receive appropriate preoperative antibiotics, such as piperacillin/tazobactam.
• Unclear diagnosis
  • In these children, the history may be consistent with appendicitis, while the examination is not, or the examination may be suggestive of appendicitis in the face of an unremarkable history. Laboratory studies, serial abdominal examinations, and radiologic studies are helpful to determine the need for surgical consultation.
  • Serial examinations of the patient in the ED along with results of the studies may help to clarify the diagnosis.
  • If uncertainty persists after a period of observation, surgical consultation should be obtained.

Evaluation rules and algorithms have been proposed to help the clinician make the correct diagnosis and treatment plan. These decision rules can help predict which children are at low risk for appendicitis. 

• One such numerically based system was proposed by Kharbanda et al.⁵
  • The proposed system is based on a 6-part scoring system: nausea (2 points), history of focal RLQ pain (2 points), migration of pain (1 point), difficulty walking (1 point), rebound tenderness/pain with percussion (2 points), and absolute neutrophil count of >6.75 X 10³/µL (6 points).
  • A score less than or equal to 5 had a sensitivity of 96.3% (95% confidence interval [CI], 87.5-99.0), a negative predictive value of 95.6% (95% CI, 90.8-99.0), and a negative likelihood ratio of 0.102 (95% CI, 0.026-0.405) in the validation set.
• The Samuel score, or Pediatric Appendicitis Score
  • This system is based on 8 variables, including migration of pain to RLQ, anorexia, nausea/vomiting, tenderness in RLQ, cough, hopping, percussion tenderness in RLQ, elevated temperature, leukocytosis, and left shift. 
  • The Samuel scoring system recommends that a score less than or equal to 5 should be observed, and a score greater than or equal to 6 should undergo surgical consultation. 
• The Alvarado, or MANTRELS score was originally derived from adult data.
  • The MANTRELS score is based on 7 variables, including migration of pain to RLQ, anorexia, nausea/vomiting, tenderness in RLQ, rebound pain, elevated temperature (>37.3), leukocytosis (>10³/µL), and left shift.
  • Schneider et al found that an Alvarado score greater than or equal to 7 yielded a sensitivity of 73% and a specificity of 80%.⁶ This scoring system is limited to risk stratification of suspected appendicitis in children.

Pediatric patients with appendicitis can undergo laparoscopic appendectomy (versus open appendectomy) without incurring a greater risk for complications.  

• Fifteen to 20% of appendectomies are performed in cases for which test results are later determined to be falsely positive, as appendicitis is difficult to diagnose in infants and toddlers.
• Nontoxic patients with a localized walled-off abscess may be candidates for initial medical management with antibiotics, followed by an elective appendectomy. 
• The keys to any evaluation and treatment plan that involve equivocal history, physical examination findings, and inconclusive supporting test results include relieving the patient's pain and discomfort early and often, communicating with the patient and family about the plans, repeating the examination often, adjusting the differential diagnosis, and keeping the patient for observation if a firm diagnosis is not made or for follow-up. Algorithms, scoring systems, imaging studies, and consultation reports are part of the clinician's armamentarium. Documentation of medical decision making is important, as is a knowledge of the current literature.

Consultations

Early consultation with a pediatric or general surgeon is important when appendicitis is suspected.

Medication

Preoperative antibiotics are given to children with suspected appendicitis and stopped after surgery if no perforation exists. Patients presenting with perforated appendicitis may be volume depleted and require aggressive fluid resuscitation. The combination of ampicillin, clindamycin, and gentamicin is administered to treat infection from aerobic and anaerobic organisms. Alternative regimens include ampicillin and sulbactam, cefoxitin, cefotetan, piperacillin and tazobactam, ticarcillin and clavulanate, and imipenem and cilastatin.

Antibiotics

Regimens should cover the most commonly encountered organisms, such as E coli, Bacteroides, Klebsiella, Enterococci, and Pseudomonas species.

Ampicillin (Omnipen, Principen)

Bactericidal activity against susceptible organisms. Alternative to amoxicillin when unable to take medication orally.

Dosing

Adult

1-2 g IV/IM q4-8h

Pediatric

100-200 mg/kg/d IV/IM divided q4-6h

Interactions

Probenecid and disulfiram elevate ampicillin levels; allopurinol decreases ampicillin effects and has additive effects on ampicillin rash; may decrease effects of oral contraceptives

Contraindications

Documented hypersensitivity

Precautions

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

Precautions

Adjust dose in renal failure; evaluate rash and differentiate from hypersensitivity reaction

Gentamicin (Garamycin)

Aminoglycoside with activity against gram-negative bacteria including Pseudomonas species. Also produces a synergistic effect when used in conjunction with a beta-lactam against Enterococci. Interferes with bacterial protein synthesis by binding to the 30S and 50S ribosomal subunits. Not the DOC. Consider if penicillins or other less toxic drugs are contraindicated, when clinically indicated, and in mixed infections caused by susceptible staphylococci and gram-negative organisms. Dosing regimens are numerous. Adjust dose based on CrCl and changes in volume of distribution. May be given IV/IM.

Dosing

Adult

1-1.5 mg/kg/dose IV/IM q8-24h

Pediatric

1.5-2.5 mg/kg/dose IV/IM q8h

Interactions

Coadministration with other aminoglycosides, cephalosporins, penicillins, and amphotericin B may increase nephrotoxicity; aminoglycosides enhance effects of neuromuscular blocking agents, thus prolonged respiratory depression may occur; coadministration with loop diuretics may increase auditory toxicity of aminoglycosides; possible irreversible hearing loss of varying degrees may occur (monitor regularly)

Contraindications

Documented hypersensitivity; non–dialysis-dependent renal insufficiency

Precautions

Pregnancy

D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus

Precautions

Narrow therapeutic index (not intended for long-term therapy); caution in renal failure (not on dialysis), myasthenia gravis, hypocalcemia, and conditions that depress neuromuscular transmission; adjust dose in renal impairment

Clindamycin (Cleocin)

Lincosamide for treatment of serious skin and soft tissue staphylococcal infections. Also effective against aerobic and anaerobic streptococci (except enterococci). Inhibits bacterial growth, possibly by blocking dissociation of peptidyl tRNA from ribosomes causing RNA-dependent protein synthesis to arrest.

Dosing

Adult

1.2-1.8 g/d IV/IM divided tid/qid

Pediatric

20-40 mg/kg/d IV/IM divided tid/qid

Interactions

Increases duration of neuromuscular blockade induced by tubocurarine and pancuronium; erythromycin may antagonize effects of clindamycin; antidiarrheals may delay absorption of clindamycin

Contraindications

Documented hypersensitivity; regional enteritis; ulcerative colitis; hepatic impairment; antibiotic-associated colitis

Precautions

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

Precautions

Adjust dose in severe hepatic dysfunction; no adjustment necessary in renal insufficiency; associated with severe and possibly fatal colitis

Piperacillin and tazobactam (Zosyn)

Antipseudomonal penicillin plus beta-lactamase inhibitor. Inhibits biosynthesis of cell wall mucopeptide and is effective during stage of active multiplication.

Dosing

Adult

4 g piperacillin with 0.5 g tazobactam IV q8h

Pediatric

<12 years: Not established
>12 years: 300-400 mg/kg/d (based on piperacillin component) IV divided q6-8h

Interactions

Tetracyclines may decrease effects of ticarcillin; high concentrations of ticarcillin may physically inactivate aminoglycosides if administered in same IV line; effects are synergistic when administered concurrently with aminoglycosides; probenecid may increase penicillin levels

Contraindications

Documented hypersensitivity; severe pneumonia, bacteremia, pericarditis, emphysema, meningitis, and purulent or septic arthritis should not be treated with an oral penicillin during the acute stage

Precautions

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

Precautions

Perform CBC prior to initiation of therapy and at least weekly during therapy; monitor for liver function abnormalities by measuring AST and ALT levels during therapy; caution in patients with hepatic insufficiencies; perform urinalysis and BUN and creatinine determinations during therapy and adjust dose if values become elevated; monitor blood levels to avoid possible neurotoxic reactions

Cefoxitin (Mefoxin)

Second-generation cephalosporin indicated for gram-positive cocci and gram-negative rod infections. Infections caused by cephalosporin-resistant or penicillin-resistant gram-negative bacteria may respond to cefoxitin. Inhibits bacterial cell wall synthesis during active multiplication by binding one or more penicillin-binding proteins.

Dosing

Adult

1-2 g IV q6-8h

Pediatric

80-100 mg/kg/d IV divided q6-8h

Interactions

Probenecid may increase effects; coadministration with aminoglycosides or furosemide may increase nephrotoxicity (closely monitor renal function)

Contraindications

Documented hypersensitivity

Precautions

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

Precautions

Dosage adjustment may be necessary in patients with renal impairment; bacterial or fungal overgrowth of nonsusceptible organisms may occur with prolonged use or repeated treatment; caution in patients with previously diagnosed colitis

Cefotetan (Cefotan)

Second-generation cephalosporin used as single-drug therapy to provide broad gram-negative coverage and anaerobic coverage. Also provides some coverage of gram-positive bacteria. Half-life is 3.5 h. Inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins; inhibits final transpeptidation step of peptidoglycan synthesis, resulting in cell wall death.
Dosage and route of administration depends on condition of patient, severity of infection, and susceptibility of causative organism.

Dosing

Adult

1-2 g IV/IM q12h for 5-10 d; not to exceed 6 g/d

Pediatric

20-40 mg/kg/dose IV/IM q12h for 5-10 d

Interactions

Consumption of alcohol within 72 h of cefotetan may produce disulfiramlike reactions; cefotetan may increase hypoprothrombinemic effects of anticoagulants; coadministration with potent diuretics (eg, loop diuretics) or aminoglycosides may increase nephrotoxicity

Contraindications

Documented hypersensitivity

Precautions

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

Precautions

Reduce dosage by 1/2 if <10-30 mL/min creatinine clearance and by 1/4 if <10 mL/min; (high doses may cause CNS toxicity); bacterial or fungal overgrowth of nonsusceptible organisms may occur with prolonged or repeated therapy

Ticarcillin and clavulanate potassium (Timentin)

Inhibits biosynthesis of cell wall mucopeptide and is effective during stage of active growth. Antipseudomonal penicillin plus beta-lactamase inhibitor that provides coverage against most gram-positives, most gram-negatives, and most anaerobes.

Dosing

Adult

3 g (based on ticarcillin component) IV q4-6h; not to exceed 18-24 g/d

Pediatric

300 mg/kg/d (based on ticarcillin component) IV divided q4-6h

Interactions

Tetracyclines may decrease effects of ticarcillin; high concentrations of ticarcillin may physically inactivate aminoglycosides if administered in same IV line; effects are synergistic when administered concurrently with aminoglycosides; probenecid may increase penicillin levels

Contraindications

Documented hypersensitivity; severe pneumonia, bacteremia, pericarditis, emphysema, meningitis, and purulent or septic arthritis should not be treated with oral penicillin during acute stage

Precautions

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

Precautions

Perform CBCs prior to initiation of therapy and at least weekly during therapy; monitor for liver function abnormalities by measuring AST and ALT levels during therapy; exercise caution in patients with hepatic insufficiencies; perform urinalysis, and BUN and creatinine determinations during therapy and adjust dose if values become elevated; monitor blood levels to avoid possible neurotoxic reactions

Imipenem and cilastatin (Primaxin)

For treatment of multiple organism infections in which other agents do not have wide-spectrum coverage or are contraindicated due to potential for toxicity.

Dosing

Adult

Base initial dose on severity of infection, and administer in equally divided doses; dose may range from 250-500 mg (based on imipenem component) q6h IV; not to exceed 3-4 g/d

Pediatric

Note: Dose is based on imipenem component
Neonates: 40-50 mg/kg/d IV divided q12h
Infants and children:
1-3 months: 100 mg/kg/d IV divided q6h
>3 months: 60-100 mg/kg/d IV divided q6h

Interactions

Coadministration with cyclosporine may increase CNS side effects of both agents; coadministration with ganciclovir may result in generalized seizures

Contraindications

Documented hypersensitivity; known hypersensitivity to amide local anesthetics; children with CNS infections (increased seizure risk); children <30 kg with renal impairment (lack of data)

Precautions

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Adjust dose in renal insufficiency (adult adjustments)
CrCl (mL/min) 80-50: 0.5 g q6-8h
CrCl 50-10: 0.5 g q8-12h
Hemodialysis (HD): 0.25-0.5 g after HD, then q12h
Adjust dose in renal insufficiency; avoid use in children <12 y with CNS infections
Caution with history of seizures, hypersensitivity to penicillins, cephalosporins, or other beta-lactam antibiotics

Analgesics

Pain management is a contentious topic for some emergency physicians and surgeons. Several classes of analgesic medications have proven safe and efficacious in the preoperative pediatric patient.

It is ethical and prudent for emergency physicians, surgeons, anesthesiologists, pediatricians, and pharmacists to agree on a plan for providing pain relief to the pediatric patient. Topics to be agreed upon include type, route, dose, and frequency of administering analgesic, antiemetic, and antipyretic agents.

Ketorolac (Toradol)

Inhibits prostaglandin synthesis by decreasing the activity of the enzyme, cyclooxygenase, which results in decreased formation of prostaglandin precursors.
With proper dosing, does not cause a significant decrease in hematocrit, increase in creatinine, or overall complications. It does have the ability to decrease hospital stay and narcotic requirements in postoperative children.

Dosing

Adult

30-60 mg IM initially followed by 15-30 mg q6h prn; not to exceed 5 d of treatment

Pediatric

Not established, data limited: 0.4-1 mg/kg IM once

Interactions

Coadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase PT when taking anticoagulants (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently

Contraindications

Documented hypersensitivity; peptic ulcer disease; recent GI bleeding or perforation; renal insufficiency; high risk of bleeding; do not administer into CNS

Precautions

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Acute renal insufficiency, hyperkalemia, hyponatremia, interstitial nephritis, and renal papillary necrosis may occur; increases risk of acute renal failure in patients with preexisting renal disease or compromised renal perfusion; low WBC counts (rare) usually return to normal during ongoing therapy; discontinue therapy if leukopenia, granulocytopenia, or thrombocytopenia persists

Fentanyl citrate (Sublimaze)

A synthetic opioid that is 75-200 times more potent and much shorter half-life than morphine sulfate. Has less hypotensive effects and is safer in patients with hyperactive airway disease than morphine because of minimal-to-no associated histamine release. By itself, it causes little cardiovascular compromise, although addition of benzodiazepines or other sedatives may result in decreased cardiac output and blood pressure.
Highly lipophilic and protein-bound. Prolonged exposure leads to accumulation in fat and delays weaning process.
Consider continuous infusion because of the short half-life of fentanyl. Parenteral form is DOC for conscious sedation analgesia. Ideal for analgesic action of short duration during anesthesia and immediate postoperative period.
Excellent choice for pain management and sedation with short duration (30-60 min) and easy to titrate. Easily and quickly reversed by naloxone.
After initial parenteral dose, subsequent parenteral doses should not be titrated more frequently than q3h or q6h thereafter.

Dosing

Adult

Emergency: 0.5-2 mcg/kg/dose IM/IV
Analgesia: 0.5-1 mcg/kg/dose IM/IV q30-60min

Pediatric

<2 years: 2-3 mcg/kg/dose IM/IV q30-60min
2-12 years: 1-2 mcg/kg/dose IM/IV q60min
>12 years: Administer as in adults

Interactions

Phenothiazines may antagonize analgesic effects of opiate agonists; tricyclic antidepressants may potentiate adverse effects of fentanyl when both drugs are used concurrently

Contraindications

Documented hypersensitivity; hypotension or potentially compromised airway where it would be difficult to establish rapid airway control

Precautions

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

Precautions

Caution in hypotension, respiratory depression, constipation, nausea, emesis, and urinary retention; idiosyncratic reaction, known as chest wall rigidity syndrome, may require neuromuscular blockade in order to increase ventilation

Morphine sulfate

Reliable and predictable effects, safety profile, and ease of reversibility with naloxone. Various IV doses are used; commonly titrated until desired effect obtained.
Remember to write legibly and clearly: morphine sulfate. JCAHO has placed the abbreviation on the banned abbreviation list. Therefore, do not abbreviate morphine as MSO4.

Dosing

Adult

Starting dose: 0.1 mg/kg IV/IM/SC
Maintenance dose: 5-20 mg/70 kg IV/IM/SC q4h
Relatively hypovolemic patients: 2 mg IV/IM/SC initially; reassess hemodynamic effects of dose

Pediatric

Infants and children: 0.1-0.2 mg/kg dose IV/IM/SC q2-4h prn; not to exceed 15 mg/dose; may initiate at 0.05 mg/kg/dose

Interactions

Phenothiazines may antagonize analgesic effects of opiate agonists; tricyclic antidepressants, MAO inhibitors, and other CNS depressants may potentiate adverse effects of morphine

Contraindications

Documented hypersensitivity; hypotension; potentially compromised airway where establishing rapid airway control would be difficult

Precautions

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Caution in hypotension, respiratory depression, nausea, emesis, constipation, urinary retention, atrial flutter, and other supraventricular tachycardias; has vagolytic action and may increase ventricular response rate

Follow-up

Further Inpatient Care

• Laparoscopic appendectomy is performed for the treatment of appendicitis.
  • Potential advantages of laparoscopic appendectomy versus open appendectomy include reduced postoperative pain and lower wound infection rate.
  • Laparoscopy can be diagnostic for alternative diagnoses.

Transfer

Transfer to a center with a pediatric or general surgeon is necessary for patients with appendicitis, after stabilization. 

Complications

Complications of appendicitis may include the following:

• Perforation
• Sepsis
• Shock
• Postoperative adhesions
• Infertility
• Wound dehiscence
• Wound infection
• Bowel obstruction

Prognosis

• The prognosis of patients with appendicitis without perforation is excellent.

Miscellaneous

Medicolegal Pitfalls

• Performing a complete examination including examination of the genitals is important. Young male patients may be hesitant to report testicular pain.  Symptoms and signs of testicular torsion and ectopic pregnancy overlap with appendicitis and have serious morbidity if not quickly diagnosed. 
• Patients should not be easily diagnosed with gastroenteritis if they have abdominal pain. Patients with nonspecific abdominal complaints should be diagnosed with abdominal pain of unknown etiology. Patients should be instructed to be reevaluated in 8-12 hours by their primary care physician or return to the ED if symptoms persist.
• Patients with an equivocal examination should be kept for observation and followed-up by serial abdominal examinations. Pain control is important in patients with abdominal pain. However, patients who improve after parenteral narcotics should be observed before discharge. 
• Early surgical consultation is key in patients with suspected appendicitis.

Special Concerns

• The emergency physician must include the patient (with age-appropriate communication) and family in all discussions about the evaluation and treatment plan.
• Relieve the patient's pain and discomfort early and often. Do not allow the pediatric patient with appendicitis to be underdosed with analgesia.
• Appendicitis should be considered in special patient populations, such as the immunocompromised and developmentally delayed. 
• Discuss with the surgeons how they would like pediatric patients evaluated and treated; for example, if imaging study should be performed before consultation, or should consultation occur before analgesia.

References

1. Rothrock SG, Pagane J. Acute appendicitis in children: emergency department diagnosis and management. Ann Emerg Med. Jul 2000;36(1):39-51. [Medline].

2. Becker T, Kharbanda A, Bachur R. Atypical clinical features of pediatric appendicitis. Acad Emerg Med. Feb 2007;14(2):124-9. [Medline].

3. Cardall T, Glasser J, Guss DA. Clinical value of the total white blood cell count and temperature in the evaluation of patients with suspected appendicitis. Acad Emerg Med. Oct 2004;11(10):1021-7. [Medline].

4. Rubin SZ, Martin DJ. Ultrasonography in the management of possible appendicitis in childhood. J Pediatr Surg. Jul 1990;25(7):737-40. [Medline].

5. [Best Evidence] Kharbanda AB, Taylor GA, Fishman SJ, Bachur RG. A clinical decision rule to identify children at low risk for appendicitis. Pediatrics. Sep 2005;116(3):709-16. [Medline].

6. [Best Evidence] Schneider C, Kharbanda A, Bachur R. Evaluating appendicitis scoring systems using a prospective pediatric cohort. Ann Emerg Med. Jun 2007;49(6):778-84, 784.e1. [Medline].

7. Addiss DG, Shaffer N, Fowler BS, Tauxe RV. The epidemiology of appendicitis and appendectomy in the United States. Am J Epidemiol. Nov 1990;132(5):910-25. [Medline].

8. Allen ED, Pfaff JK, Taussig LM, McCoy KS. The clinical spectrum of chronic appendiceal abscess in cystic fibrosis. Am J Dis Child. Oct 1992;146(10):1190-3. [Medline].

9. Alloo J, Gerstle T, Shilyansky J, Ein SH. Appendicitis in children less than 3 years of age: a 28-year review. Pediatr Surg Int. Jan 2004;19(12):777-9. [Medline].

10. Andersson N, Griffiths H, Murphy J, et al. Is appendicitis familial?. Br Med J. Sep 22 1979;2(6192):697-8. [Medline].

11. Brender JD, Marcuse EK, Koepsell TD, Hatch EI. Childhood appendicitis: factors associated with perforation. Pediatrics. Aug 1985;76(2):301-6. [Medline].

12. Brender JD, Marcuse EK, Weiss NS, Koepsell TD. Is childhood appendicitis familial?. Am J Dis Child. Apr 1985;139(4):338-40. [Medline].

13. Brennan GD. Pediatric appendicitis: pathophysiology and appropriate use of diagnostic imaging. CJEM. Nov 2006;8(6):425-32. [Medline].

14. Brook I. Clinical review: bacteremia caused by anaerobic bacteria in children. Crit Care. Jun 2002;6(3):205-11. [Medline].

15. Buck ML. Clinical experience with ketorolac in children. Ann Pharmacother. Sep 1994;28(9):1009-13. [Medline].

16. Bundy DG, Byerley JS, Liles EA, Perrin EM, Katznelson J, Rice HE. Does this child have appendicitis?. JAMA. Jul 25 2007;298(4):438-51. [Medline].

17. Chande VT, Kinnane JM. Role of the primary care provider in expediting care of children with acute appendicitis. Arch Pediatr Adolesc Med. Jul 1996;150(7):703-6. [Medline].

18. Chung RS, Rowland DY, Li P, Diaz J. A meta-analysis of randomized controlled trials of laparoscopic versus conventional appendectomy. Am J Surg. Mar 1999;177(3):250-6. [Medline].

19. Crady SK, Jones JS, Wyn T, Luttenton CR. Clinical validity of ultrasound in children with suspected appendicitis. Ann Emerg Med. Jul 1993;22(7):1125-9. [Medline].

20. Doherty GM, Lewis FR Jr. Appendicitis: continuing diagnostic challenge. Emerg Med Clin North Am. Aug 1989;7(3):537-53. [Medline].

21. Eldar S, Nash E, Sabo E, et al. Delay of surgery in acute appendicitis. Am J Surg. Mar 1997;173(3):194-8. [Medline].

22. Emil S, Laberge JM, Mikhail P, et al. Appendicitis in children: a ten-year update of therapeutic recommendations. J Pediatr Surg. Feb 2003;38(2):236-42. [Medline].

23. Etensel B, Yazici M, Gürsoy H, Ozkisacik S, Erkus M. The effect of blunt abdominal trauma on appendix vermiformis. Emerg Med J. Dec 2005;22(12):874-7. [Medline].

24. Gardikis S, Touloupidis S, Dimitriadis G, et al. Urological symptoms of acute appendicitis in childhood and early adolescence. Int Urol Nephrol. 2002;34(2):189-92. [Medline].

25. Gauderer MW, Crane MM, Green JA, DeCou JM, Abrams RS. Acute appendicitis in children: the importance of family history. J Pediatr Surg. Aug 2001;36(8):1214-7. [Medline].

26. Goldman RD, Crum D, Bromberg R, Rogovik A, Langer JC. Analgesia administration for acute abdominal pain in the pediatric emergency department. Pediatr Emerg Care. Jan 2006;22(1):18-21. [Medline].

27. Guagliardo MF, Teach SJ, Huang ZJ, Chamberlain JM, Joseph JG. Racial and ethnic disparities in pediatric appendicitis rupture rate. Acad Emerg Med. Nov 2003;10(11):1218-27. [Medline].

28. Guthery SL, Hutchings C, Dean JM, Hoff C. National estimates of hospital utilization by children with gastrointestinal disorders: analysis of the 1997 kids' inpatient database. J Pediatr. May 2004;144(5):589-94. [Medline].

29. Hennington MH, Tinsley EA Jr, Proctor HJ, Baker CC. Acute appendicitis following blunt abdominal trauma. Incidence or coincidence?. Ann Surg. Jul 1991;214(1):61-3. [Medline].

30. Henry MC, Moss RL. Primary versus delayed wound closure in complicated appendicitis: an international systematic review and meta-analysis. Pediatr Surg Int. Aug 2005;21(8):625-30. [Medline].

31. Hobson MJ, Carney DE, Molik KA, et al. Appendicitis in childhood hematologic malignancies: analysis and comparison with typhilitis. J Pediatr Surg. Jan 2005;40(1):214-9; discussion 219-20. [Medline].

32. Houry D, Colwell C, Ott C. Abdominal pain in a child after blunt abdominal trauma: an unusual injury. J Emerg Med. Oct 2001;21(3):239-41. [Medline].

33. Jabra AA, Shalaby-Rana EI, Fishman EK. CT of appendicitis in children. J Comput Assist Tomogr. Jul-Aug 1997;21(4):661-6. [Medline].

34. Kim MK, Strait RT, Sato TT, Hennes HM. A randomized clinical trial of analgesia in children with acute abdominal pain. Acad Emerg Med. Apr 2002;9(4):281-7. [Medline].

35. Kosloske AM, Love CL, Rohrer JE, Goldthorn JF, Lacey SR. The diagnosis of appendicitis in children: outcomes of a strategy based on pediatric surgical evaluation. Pediatrics. Jan 2004;113(1 Pt 1):29-34. [Medline].

36. Kwok MY, Kim MK, Gorelick MH. Evidence-based approach to the diagnosis of appendicitis in children. Pediatr Emerg Care. Oct 2004;20(10):690-8; quiz 699-701. [Medline].

37. Mohammed AA, Daghman NA, Aboud SM, Oshibi HO. The diagnostic value of C-reactive protein, white blood cell count and neutrophil percentage in childhood appendicitis. Saudi Med J. Sep 2004;25(9):1212-5. [Medline].

38. Moraitis D, Kini SU, Annamaneni RK, Zitsman JL. Laparoscopy in complicated pediatric appendicitis. JSLS. Oct-Dec 2004;8(4):310-3. [Medline].

39. Musemeche CA, Baker JL. Acute appendicitis: a cause of recurrent abdominal pain in pediatric trauma. Pediatr Emerg Care. Feb 1995;11(1):30-1. [Medline].

40. Nance ML, Adamson WT, Hedrick HL. Appendicitis in the young child: a continuing diagnostic challenge. Pediatr Emerg Care. Jun 2000;16(3):160-2. [Medline].

41. Nikolaidis P, Hwang CM, Miller FH, Papanicolaou N. The nonvisualized appendix: incidence of acute appendicitis when secondary inflammatory changes are absent. AJR Am J Roentgenol. Oct 2004;183(4):889-92. [Medline].

42. Nwomeh BC, Chisolm DJ, Caniano DA, Kelleher KJ. Racial and socioeconomic disparity in perforated appendicitis among children: where is the problem?. Pediatrics. Mar 2006;117(3):870-5. [Medline].

43. O'Shea JS, Bishop ME, Alario AJ, Cooper JM. Diagnosing appendicitis in children with acute abdominal pain. Pediatr Emerg Care. Sep 1988;4(3):172-6. [Medline].

44. Oka T, Kurkchubasche AG, Bussey JG, Wesselhoeft CW Jr, Tracy TF Jr, Luks FI. Open and laparoscopic appendectomy are equally safe and acceptable in children. Surg Endosc. Feb 2004;18(2):242-5. [Medline].

45. Partrick DA, Janik JE, Janik JS, Bensard DD, Karrer FM. Increased CT scan utilization does not improve the diagnostic accuracy of appendicitis in children. J Pediatr Surg. May 2003;38(5):659-62. [Medline].

46. Pearl RH, Hale DA, Molloy M, Schutt DC, Jaques DP. Pediatric appendectomy. J Pediatr Surg. Feb 1995;30(2):173-8; discussion 178-81. [Medline].

47. Pelizzo G, La Riccia A, Bouvier R, Chappuis JP, Franchella A. Carcinoid tumors of the appendix in children. Pediatr Surg Int. Jul 2001;17(5-6):399-402. [Medline].

48. Ponsky TA, Huang ZJ, Kittle K, et al. Hospital- and patient-level characteristics and the risk of appendiceal rupture and negative appendectomy in children. JAMA. Oct 27 2004;292(16):1977-82. [Medline].

49. Reynolds SL. Missed appendicitis in a pediatric emergency department. Pediatr Emerg Care. Feb 1993;9(1):1-3. [Medline].

50. Reynolds SL, Jaffe DM. Diagnosing abdominal pain in a pediatric emergency department. Pediatr Emerg Care. Jun 1992;8(3):126-8. [Medline].

51. Rhea JT, Halpern EF, Ptak T, Lawrason JN, Sacknoff R, Novelline RA. The status of appendiceal CT in an urban medical center 5 years after its introduction: experience with 753 patients. AJR Am J Roentgenol. Jun 2005;184(6):1802-8. [Medline].

52. Rothrock SG, Skeoch G, Rush JJ, Johnson NE. Clinical features of misdiagnosed appendicitis in children. Ann Emerg Med. Jan 1991;20(1):45-50. [Medline].

53. Rowe M, O'Neil J, Grosfeld J. Appendicitis. In: Essentials of Pediatric Surgery. 1995:579-85.

54. Rusnak RA, Borer JM, Fastow JS. Misdiagnosis of acute appendicitis: common features discovered in cases after litigation. Am J Emerg Med. Jul 1994;12(4):397-402. [Medline].

55. Samuel M. Pediatric appendicitis score. J Pediatr Surg. Jun 2002;37(6):877-81. [Medline].

56. Scholer SJ, Pituch K, Orr DP, Dittus RS. Use of the rectal examination on children with acute abdominal pain. Clin Pediatr (Phila). May 1998;37(5):311-6. [Medline].

57. Schwartz MZ, Bulas D. Acute abdomen. Laboratory evaluation and imaging. Semin Pediatr Surg. May 1997;6(2):65-73. [Medline].

58. Selbst SM, Friedman MJ, Singh SB. Epidemiology and etiology of malpractice lawsuits involving children in US emergency departments and urgent care centers. Pediatr Emerg Care. Mar 2005;21(3):165-9. [Medline].

59. Serour F, Efrati Y, Klin B, Shikar S, Weinberg M, Vinograd I. Acute appendicitis following abdominal trauma. Arch Surg. Jul 1996;131(7):785-6. [Medline].

60. Siegel MJ, Carel C, Surratt S. Ultrasonography of acute abdominal pain in children. JAMA. Oct 9 1991;266(14):1987-9. [Medline].

61. Smink DS, Fishman SJ, Kleinman K, Finkelstein JA. Effects of race, insurance status, and hospital volume on perforated appendicitis in children. Pediatrics. Apr 2005;115(4):920-5. [Medline].

62. Stephen AE, Segev DL, Ryan DP, et al. The diagnosis of acute appendicitis in a pediatric population: to CT or not to CT. J Pediatr Surg. Mar 2003;38(3):367-71; discsussion 367-71. [Medline].

63. Stringel G. Appendicitis in children: a systematic approach for a low incidence of complications. Am J Surg. Dec 1987;154(6):631-5. [Medline].

64. Strouse PJ, DiPietro MA, Saez F. Transient small-bowel intussusception in children on CT. Pediatr Radiol. May 2003;33(5):316-20. [Medline].

65. Tantoco JG, Levitt MA, Hollands CM, Brisseau GF, Caty MG, Glick PL. Reduced social morbidity of laparoscopic appendectomy in children. Am Surg. Sep 2004;70(9):779-82. [Medline].

66. Taylor GA, Callahan MJ, Rodriguez D, Smink DS. CT for suspected appendicitis in children: an analysis of diagnostic errors. Pediatr Radiol. Apr 2006;36(4):331-7. [Medline].

67. Taylor M, Emil S, Nguyen N, Ndiforchu F. Emergent vs urgent appendectomy in children: a study of outcomes. J Pediatr Surg. Dec 2005;40(12):1912-5. [Medline].

68. van den Broek WT, van der Ende ED, Bijnen AB, Breslau PJ, Gouma DJ. Which children could benefit from additional diagnostic tools in case of suspected appendicitis?. J Pediatr Surg. Apr 2004;39(4):570-4. [Medline].

69. Yacoe ME, Jeffrey RB Jr. Sonography of appendicitis and diverticulitis. Radiol Clin North Am. Sep 1994;32(5):899-912. [Medline].

70. Yardeni D, Hirschl RB, Drongowski RA, Teitelbaum DH, Geiger JD, Coran AG. Delayed versus immediate surgery in acute appendicitis: do we need to operate during the night?. J Pediatr Surg. Mar 2004;39(3):464-9; discussion 464-9. [Medline].

71. Zhou H, Chen YC, Zhang JZ. Abdominal pain among children re-evaluation of a diagnostic algorithm. World J Gastroenterol. Oct 2002;8(5):947-51. [Medline].

Keywords

appendicitis, appendicitis in children, acute inflammation of the appendix, abdominal pain, appendix, acute appendicitis, appendiceal inflammation, peritonitis

Contributor Information and Disclosures

Author

Kara E Hennelly, MD, Fellow, Department of Pediatric Emergency Medicine, Children's Hospital Boston
Kara E Hennelly, MD is a member of the following medical societies: American Academy of Pediatrics
Disclosure: Nothing to disclose.

Coauthor(s)

Richard G Bachur, MD, Assistant Professor of Pediatrics, Harvard Medical School; Associate Chief and Fellowship Director, Attending Physician, Division of Emergency Medicine, Children's Hospital of Boston
Richard G Bachur, MD is a member of the following medical societies: American Academy of Pediatrics, Society for Academic Emergency Medicine, and Society for Pediatric Research
Disclosure: Nothing to disclose.

Medical Editor

Kirsten A Bechtel, MD, Associate Professor of Pediatrics, Department of Pediatrics, Yale University School of Medicine; Consulting Staff, Department of Pediatric Emergency Medicine, Yale-New Haven Children's Hospital
Kirsten A Bechtel, MD is a member of the following medical societies: American Academy of Pediatrics
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

Wayne Wolfram, MD, MPH, Clinical Associate Professor, Departments of Pediatrics, Children's Hospital and University of Cincinnati
Wayne Wolfram, MD, MPH is a member of the following medical societies: American Academy of Emergency Medicine, American Academy of Pediatrics, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Richard G Bachur, MD, Assistant Professor of Pediatrics, Harvard Medical School; Associate Chief and Fellowship Director, Attending Physician, Division of Emergency Medicine, Children's Hospital of Boston
Richard G Bachur, MD is a member of the following medical societies: American Academy of Pediatrics, Society for Academic Emergency Medicine, and Society for Pediatric Research
Disclosure: Nothing to disclose.

© 1994- by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)